In part 4 of this Exclusive Interview, Tim Dunn discusses the success of the use of the FreeStyle Libre among youth in a talk with Diabetes in Control Publisher Steve Freed.

In part 5 of this Exclusive Interview, Tim Dunn talks with Diabetes in Control Publisher Steve Freed about software that can help medical professionals to interpret the data of the CGM system.

In part 6, the conclusion of this Exclusive Interview, Tim Dunn shares how to access more info about the FreeStyle Libre in a talk with Diabetes in Control Publisher Steve Freed.

'Authorized generic' of Humalog 100 to sell for $137.35 per vial, 50 percent lower than list price

This week Sheri R. Colberg, PhD, FACSM has an interesting feature on exercise and glucose levels. In her in-depth review she presents concepts that may change how you advise your patients on eating before during and after exercise. One of the things that we often do is discount the consumption …

By Sheri R. Colberg, PhD, FACSM

There is no official ideal blood glucose range to start with and maintain during physical activity, but we do know that being too low negatively impacts performance, as does being too high. As for what blood glucose target or range most athletes aim for, it depends on a number of factors, including the type, intensity, and duration of their activity. A consensus statement about exercise and type 1 diabetes published in The Lancet in 2017 suggested that a reasonable target for most people doing aerobic exercise lasting up to an hour is 126 to 180 mg/dL (7.0 to 10.0 mmol/L), only aiming higher for added protection against lows in some situations.

New evidence suggests added consideration of the protein and fat.

Reusable smart insulin pens to launch first, followed by Bluetooth attachment for disposable pens later in 2019.

Mean decrease in HbA1c greater than that seen with health care professional support only

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Risk Factors …